143rd Meeting of the National Advisory Council on Drug Abuse
Virtual Meeting – February 8, 2023
Closed Session
This meeting is closed to the public in accordance with the provisions set forth in section 552b{c}(4) and 552b{c}(6), Title 5, U.S. Code and section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2).
Time | Presentation |
---|---|
11:00 a.m. | Call to Order Nora Volkow, M.D. Director, NIDA Review of Policy and Procedures Susan Weiss, Ph.D. Executive Secretary National Advisory Council on Drug Abuse Director, Division of Extramural Research, NIDA |
11:15 a.m. |
Council Review of Grant Applications Office of Research Training, Diversity, and Disparities (ORTDD) Division of Epidemiology, Services, and Prevention Research (DESPR) Office of Translational Initiatives and Program Innovationa (OTIPI) Division of Therapeutics and Medical Consequences (DTMC) Division of Neuroscience and Behavior (DNB) Brief Break |
12:15 p.m. | Report to Council from the Board of Scientific Counselors (BSC) Amy Newman, Ph.D., Director, NIDA IRP; John Mantsch, Ph.D., BSC Chair |
12:45 p.m. | Break |
Videocast:
Members of the public who may wish to express views regarding any items discussed during this meeting may do so by writing Gillian Acca, within ten days of the meeting. Any written statements by members of the public will receive careful consideration.
Join the Videocast
Open Session
Time | Presentation |
---|---|
1:15 p.m. | Welcome and Opening Remarks Nora Volkow, M.D., Director, NIDA |
1:30 p.m. | Director's Report Nora Volkow, M.D., Director, NIDA |
2:20 p.m. | Discussion Council Members |
2:45 p.m. | What’s HOT at the NIDA-IRP Amy Newman, Ph.D., Director, NIDA IRP |
3:15 p.m. | Break |
3:30 p.m. | MERIT Award Discussion Susan Weiss, Ph.D. Director, Division of Extramural Research, NIDA |
4:00 p.m. | Medications Development Council Workgroup Report Iván Montoya, M.D., M.P.H. Acting Director, DTMC |
4:15 p.m. |
Concept Clearances
|
4:45 p.m. | Public Comments |
5:00 p.m. | Adjourn |